Vancouver, B.C., April 16, 2019 –Orion Nutraceuticals Inc., (CSE: ORI) (OTCQB: ORONF) (the “Company” or “Orion”) is pleased to announce that it has been made eligible for DTC electronic settlement and transfer of its common shares in the United States under the OTC symbol ORONF.

This approval opens Orion up to the most important and influential investment market on the planet. Due to its progressive cannabis laws, Canada has become the Mecca for cannabis investment worldwide. Orion not only has a foothold in Canada but is expanding into the US and internationally to build a global brand.

“We are very pleased to be trading on the US market as it will provide our American investors with timely news and information to help them better analyze, value and trade our securities,” said Christopher Cherry, CFO of Orion. “Without a US symbol it is difficult for Americans to buy shares in a Canadian company. This removes that barrier and is very timely for Orion as we are currently in talks with several US companies in the cannabis space.”

About Orion Nutraceuticals Inc.
Orion Nutraceuticals Inc. aims to set a new standard in cannabis life science by producing and developing innovative products with key strategic partners in the industry. In conjunction with its professional sports strategic alliances, the company is poised to advance research and development in the plant science sector, deliver science-based products and services, and market CBD therapies to the mainstream with proprietary brands and products. Orion shares trade in Canada on the CSE under the symbol ORI.


Orion Nutraceuticals Inc.

Investor Relations